[Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples